Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples